140 results
Page 3 of 7
POSASR
idj2ao7obnez17 u7
30 Mar 22
Automatic shelf registration (post-effective amendment)
7:57am
POSASR
EX-5.1
aisxv u0vm
30 Mar 22
Automatic shelf registration (post-effective amendment)
7:57am
8-K
EX-99.1
x21e04 zk
14 Sep 21
Orchard Therapeutics Bolsters R&D and Technical Operations Leadership with New Executive Appointments
7:00am
S-8
EX-5.1
jjk9hbunj2ipqv
4 Aug 21
Registration of securities for employees
4:06pm
8-K
EX-99.1
0gvfe4
4 Aug 21
Orchard Therapeutics Reports Second Quarter 2021 Financial Results and Highlights Recent Business Updates
7:05am
8-K
EX-99.1
lpqzc8 rdkhot0pfcp23
1 Jul 21
Highlights the broader potential of Orchard’s ex vivo HSC gene therapy platform approach in new and larger indications
5:02pm
8-K
ytgeyrnsa 065am
1 Jul 21
Highlights the broader potential of Orchard’s ex vivo HSC gene therapy platform approach in new and larger indications
5:02pm